Concepedia

Jim Cairns

JC

Statistics

Publications

2

Citations

56

H-Index

2

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jim Cairns is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, cannabinoid pharmacology, and potency optimization.

Publications per year

2010–2010

2

Publications

2

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Julia M. Adam, Jim Cairns, Wilson Caulfield et al. · MedChemComm · 2010 · 36 citations

, , +17

Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists

Elizabeth M. Moir, Kazuya Yoshiizumi, Jim Cairns et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 20 citations · Full text

, , +12

1–2 of 2